Ongoing studies of SIR-Spheres® Y-90 resin microspheres in the treatment of HCC

Title Setting Sponsor Study ID Treatment Arm(s) N Location
Study to compare selective internal radiation therapy (SIRT) versus sorafenib in locally advanced hepatocellular carcinoma
Hepatocellular carcinoma Collaborative Group Study NCT01135056 Sorafenib versus SIR-Spheres microspheres 360 Asia-Pacific
Sorafenib versus radioembolization in advanced hepatocellular carcinoma
Hepatocellular carcinoma Collaborative Group Study NCT01482442 Sorafenib versus SIR-Spheres microspheres 460 France
SORAMIC Sorafenib and micro-therapy guided by Primovist-enhanced MRI in patients with inoperable liver cancer
Hepatocellular carcinoma Investigator-Initiated Research Study NCT01126645 Sorafenib versus SIR-Spheres microspheres > Sorafenib 420 Europe

Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.



This content is intended for healthcare professionals only

By clicking "Yes" you are confirming that you are a healthcare professional. If you are not a healthcare professional, then please click "Go to Homepage" which will direct you to the Sirtex homepage.

Yes Go to Homepage